Vitro Diagnostics Inc (fka VODG)

[dg33]

This showed up in my Schwab newsfeed about an hour ago.

Dow Jones - July 1, 2024 2:35 pm

Vitro Biopharma to Offer 1 Million Shares in Initial Public Offering

The regenerative medicine and cellular therapy company expects to price its offering between $5 a share and $6 a share, according to a securities filing. It expects net proceeds around $4.7 million based on a public offering priced at the midpoint of its guidance. Vitro intends to use the net proceeds to advance the continued development of its AlloRx Stem Cell therapy candidate, among other efforts. Vitro said its common stock has been approved for listing on the New York Stock Exchange American under the ticker VTRO.

Write to Denny Jacob at [e-mail]